{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:08:15Z","timestamp":1791497295116,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fundaci\u00f3n xti xtod@s"},{"DOI":"10.13039\/100011941","name":"Government of Principality of Asturias","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/01576"],"award-info":[{"award-number":["PI23\/01576"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009589","name":"Lair Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDAS222516AGUI"],"award-info":[{"award-number":["PRDAS222516AGUI"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118253","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T18:14:08Z","timestamp":1749838448000},"page":"118253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"189","author":[{"given":"Christian","family":"Sordo-Bahamonde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mart\u00ednez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Granda-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candelaria","family":"Aguilar-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P.","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Carballo","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda Morais","family":"Bras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel R.","family":"Payer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seila","family":"Lorenzo-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Segundo","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118253_bib1","article-title":"Chronic lymphocytic leukaemia","volume":"3","author":"Kipps","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118253_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41408-022-00756-9","article-title":"Chronic lymphocytic leukemia treatment algorithm 2022","volume":"12","author":"Hampel","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biopha.2025.118253_bib3","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2025.118253_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41375-018-0250-6","article-title":"Control of chronic lymphocytic leukemia development by clonally-expanded CD8(+) T-cells that undergo functional exhaustion in secondary lymphoid tissues","volume":"33","author":"Hanna","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118253_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594556","article-title":"Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia","volume":"11","author":"Griggio","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1182\/blood-2015-03-567388","article-title":"Perturbation of the normal immune system in patients with CLL","volume":"126","author":"Forconi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib7","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00262-023-03435-1","article-title":"BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia","volume":"72","author":"Sordo-Bahamonde","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2025.118253_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092112","article-title":"LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia","volume":"13","author":"Sordo-Bahamonde","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118253_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081766","article-title":"S: BTLA\/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.","volume":"13","author":"Sordo-Bahamonde","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.118253_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1297116","article-title":"p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation","volume":"12","author":"Lopresti","year":"2024","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118253_bib11","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3324\/haematol.2022.282177","article-title":"The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy","volume":"108","author":"Arruga","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118253_bib12","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/bloodadvances.2022007034","article-title":"Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells","volume":"6","author":"van Bruggen","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2025.118253_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118253_bib14","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41375-024-02392-7","article-title":"Third-generation anti-CD19 CAR T cells for relapsed\/refractory chronic lymphocytic leukemia: a phase 1\/2 study","volume":"38","author":"Derigs","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118253_bib15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1158\/2767-9764.CRC-22-0200","article-title":"Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL","volume":"2","author":"Collins","year":"2022","journal-title":"Cancer Res Commun."},{"key":"10.1016\/j.biopha.2025.118253_bib16","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.4049\/jimmunol.1801359","article-title":"Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells","volume":"202","author":"Do","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib17","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","article-title":"Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL","volume":"129","author":"Ding","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000723","article-title":"Progressive Multifocal Leukoencephalopathy in B-CLL Successfully Treated With Venetoclax and Pembrolizumab","volume":"6","author":"Olivieri","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.biopha.2025.118253_bib19","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1111\/bjh.16762","article-title":"Pembrolizumab in relapsed or refractory Richter syndrome","volume":"190","author":"Armand","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118253_bib20","article-title":"Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.biopha.2025.118253_bib21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1158\/2326-6066.CIR-23-0568","article-title":"ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms","volume":"12","author":"Tian","year":"2024","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.biopha.2025.118253_bib22","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201811","article-title":"LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy","volume":"218","author":"Sharma","year":"2021","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.biopha.2025.118253_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41423-019-0321-2","article-title":"LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells","volume":"17","author":"Li","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/2326-6066.CIR-19-0036","article-title":"Disrupting LILRB4\/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development","volume":"7","author":"Gui","year":"2019","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.biopha.2025.118253_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41586-018-0615-z","article-title":"LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration","volume":"562","author":"Deng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118253_bib26","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1080\/10428194.2020.1723014","article-title":"LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents","volume":"61","author":"Chien","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.biopha.2025.118253_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cyto.b.20164","article-title":"Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia","volume":"72","author":"Colovai","year":"2007","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.biopha.2025.118253_bib28","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1182\/blood-2017-03-775858","article-title":"Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia","volume":"130","author":"Zurli","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib29","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/leu.2017.11","article-title":"Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood","volume":"31","author":"Herndon","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118253_bib31","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","article-title":"Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells","volume":"17","author":"Calissano","year":"2011","journal-title":"Mol. Med"},{"key":"10.1016\/j.biopha.2025.118253_bib32","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1093\/bioinformatics\/btw519","article-title":"shinyGEO: a web-based application for analyzing gene expression omnibus datasets","volume":"32","author":"Dumas","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2025.118253_bib33","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3389\/fimmu.2019.02455","article-title":"The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling","volume":"10","author":"Lorenzo-Herrero","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib34","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.4049\/jimmunol.178.11.7432","article-title":"Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients","volume":"178","author":"Suciu-Foca","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib35","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","article-title":"Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3","volume":"106","author":"Penna","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2019.00475","article-title":"Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets","volume":"10","author":"Tomic","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib37","unstructured":"Jaime Darce S.M.L., Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev: Anti-ilt3 antibodies and antibody drug conjugates. vol. US20200031926A1: Bluefin Biomedicine Inc; 2019."},{"key":"10.1016\/j.biopha.2025.118253_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102381","article-title":"Tumor-derived immunoglobulin-like transcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma","volume":"56","author":"Wang","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2025.118253_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/bs.mie.2019.05.036","article-title":"Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay","volume":"631","author":"Lorenzo-Herrero","year":"2020","journal-title":"Methods Enzym."},{"key":"10.1016\/j.biopha.2025.118253_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.5060","article-title":"Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia","volume":"245","author":"Garcia-Barchino","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2025.118253_bib41","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/eji.201344030","article-title":"Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells","volume":"44","author":"Wang","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2019.00095","article-title":"Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease","volume":"10","author":"Rip","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib43","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1182\/blood-2014-06-585216","article-title":"FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation","volume":"125","author":"Oellerich","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib44","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.2020005964","article-title":"TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target","volume":"137","author":"Kennedy","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjh.15516","article-title":"Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes","volume":"183","author":"Palma","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2025.118253_bib46","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/1759-7714.14991","article-title":"Prognostic impact of LILRB4 expression on tumor-infiltrating cells in resected non-small cell lung cancer","volume":"14","author":"Kumata","year":"2023","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.biopha.2025.118253_bib47","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2337\/db08-0054","article-title":"Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD\/SCID mice","volume":"57","author":"Vlad","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118253_bib48","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.humimm.2008.08.286","article-title":"CD8+ T suppressor cells and the ILT3 master switch","volume":"69","author":"Vlad","year":"2008","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40164-024-00536-0","article-title":"CAR-T cell combination therapies in hematologic malignancies","volume":"13","author":"Zhou","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2025.118253_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914780","article-title":"Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review","volume":"24","author":"Perez-Moreno","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118253_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41591-023-02722-9","article-title":"Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial","volume":"30","author":"Al-Sawaf","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2025.118253_bib52","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.immuni.2023.09.001","article-title":"Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells","volume":"56","author":"Agarwal","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2025.118253_bib53","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0003-9993(96)90137-9","article-title":"Lower extremity injuries in college athletes: relation between ligamentous laxity and lower extremity muscle tightness","volume":"77","author":"Krivickas","year":"1996","journal-title":"Arch. Phys. Med Rehabil."},{"key":"10.1016\/j.biopha.2025.118253_bib54","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.prp.2018.07.026","article-title":"Expression of ILT3 predicts poor prognosis and is inversely associated with infiltration of CD45RO+ T cells in patients with colorectal cancer","volume":"214","author":"Liu","year":"2018","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.biopha.2025.118253_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2020.10.048","article-title":"ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer","volume":"501","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118253_bib56","first-page":"3650","article-title":"LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma","volume":"109","author":"Gong","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118253_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cyto.b.21050","article-title":"Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation","volume":"84","author":"Dobrowolska","year":"2013","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.biopha.2025.118253_bib58","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1014242","article-title":"Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer","volume":"4","author":"de Goeje","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2025.118253_bib59","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/s41375-022-01656-4","article-title":"Identification of proliferative and non-proliferative subpopulations of leukemic cells in CLL","volume":"36","author":"Cuthill","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118253_bib60","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41419-024-06883-4","article-title":"LILRB4 regulates multiple myeloma development through STAT3-PFKFB1 pathway","volume":"15","author":"Xie","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118253_bib61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/bloodadvances.2019000817","article-title":"CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation","volume":"4","author":"Bartholdy","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2025.118253_bib62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12012-023-09824-3","article-title":"Downregulation of LILRB4 Promotes Human Aortic Smooth Muscle Cell Contractile Phenotypic Switch and Apoptosis in Aortic Dissection","volume":"24","author":"Xiong","year":"2024","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.biopha.2025.118253_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2018.11.137","article-title":"Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-kappaB signaling","volume":"509","author":"Li","year":"2019","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118253_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/genes15111434","article-title":"NF-KappaB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter's Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics","volume":"15","author":"Rohan","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.biopha.2025.118253_bib65","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/eji.200839188","article-title":"New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1)","volume":"39","author":"Jiang","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib66","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2060907","article-title":"LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs","volume":"11","author":"Su","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2025.118253_bib67","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4049\/jimmunol.1700553","article-title":"ILT3.Fc-CD166 Interaction Induces Inactivation of p70 S6 Kinase and Inhibits Tumor Cell Growth","volume":"200","author":"Xu","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106432","article-title":"Ibrutinib restores immune cell numbers and function in first-line and relapsed\/refractory chronic lymphocytic leukemia","volume":"97","author":"Solman","year":"2020","journal-title":"Leuk. Res"},{"key":"10.1016\/j.biopha.2025.118253_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106520","article-title":"Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia","volume":"102","author":"Solman","year":"2021","journal-title":"Leuk. Res"},{"key":"10.1016\/j.biopha.2025.118253_bib70","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3324\/haematol.2019.238154","article-title":"Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice","volume":"106","author":"Hanna","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118253_bib71","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1182\/blood-2015-11-679134","article-title":"Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia","volume":"127","author":"Fraietta","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.118253_bib72","first-page":"697","article-title":"Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3)","volume":"8","author":"Cortesini","year":"2007","journal-title":"JOP"},{"key":"10.1016\/j.biopha.2025.118253_bib73","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.intimp.2006.07.017","article-title":"Immunosuppressive activity of recombinant ILT3","volume":"6","author":"Vlad","year":"2006","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118253_bib74","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.4049\/jimmunol.176.5.2790","article-title":"Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells","volume":"176","author":"Kim-Schulze","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.118253_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40364-024-00647-0","article-title":"Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:51:59Z","timestamp":1762311119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225004470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":75,"alternative-id":["S0753332225004470"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118253","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118253"}}